Loading viewer...
investor_presentation
Format: PDF investor_presentation
Jussi Pesonen President and CEO 24 July 2018UPM Half Year Financial Report 2018
24 July 2018UPM Half Year
Financial Report 2018
| © UPM –The Biofore Company
2Q2 2018: Commercial success drives growth in
sales and earnings –strong outlook for H2 2018
•Sales grew by 5% to EUR 2,589m
•Comparable EBIT increased by 24% to
•Sales margins improved, as prices increased
in all business areas, outweighing the impact
of higher input costs
•Q2 performance was held back by several
significant scheduled maintenance shutdowns
•Operating cash flow was EUR 329m (269m)
050100150200250300350400EURmComparable EBIT
270| © UPM –The Biofore Company
3Q2 2018: Sales prices increased in all business areas,
outweighing the impact of higher input costs
•Good demand, deliveries -4%
•Price increases more than offset the variable
costs increasesUPM COMMUNICATION PAPERS
•Tight market, deliveries -3%
•Price increases more than offset the
variable costs increasesUPM RAFLATAC
•Good demand, deliveries -2%
•Price increases more than offset input
•Electricity deliveries +15%
•Higher electricity market prices
•Power generation impacted by maintenance
shutdown at the Olkiluoto power plantUPM BIOREFINING
•Good market demand. Pulp deliveries -8%,
Preview truncated — download the full document for the complete content.
Samsung Electronics Investor Presentation 2018
investor_presentationinvestor_presentation
23 Pages
Samsung Electronics Co., Ltd.
investor_presentation
Alliance Entertainment Investor Presentation 2022
investor_presentationinvestor_presentation
24 Pages
Alliance Entertainment Holding Corporation
investor_presentation
RxSight
Tonix Pharmaceuticals Investor Presentation 2022
investor_presentationinvestor_presentation
40 Pages
Tonix Pharmaceuticals Holding Corp.